Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 30, 2020 at 5:00 pm (Eastern Time) to discuss the financial results for the second quarter of 2020, recent business developments, revenue guidance for the third quarter of 2020, and financial outlook for full year 2020.

This conference call can be accessed live by telephone or by webcast:

Live Teleconference Information:Dial in number: (855) 766-6521International dial in number: (262) 912-6157Conference ID: 7380905Live Webcast Information:Visit https://edge.media-server.com/mmc/p/bkkqx6kk for the live webcast feed.

A replay of the call can be accessed on Emergent’s website emergentbiosolutions.com under “Investors.”

About Emergent BioSolutionsEmergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information visit www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:Robert G. BurrowsVice President, Investor Relations240-631-3280BurrowsR@ebsi.com

Media Contact:Miko B. NeriSenior Director, Corporate Communications240-631-3392NeriM@ebsi.com

Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Emergent Biosolutions Charts.
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Emergent Biosolutions Charts.